Corrigendum to "Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study" [Lung Cancer 130 (2019) (April) 216-225].

Autor: Steffens CC; SKH Studien GmbH, Hamburg, Germany., Elender C; Klinikum Dortmund, Klinik Nord Onkologie und Pneumologie, Dortmund, Germany., Hutzschenreuter U; Hämatologisch-Onkologische Gemeinschaftspraxis, Nordhorn, Germany., Dille S; Medical Department, iOMEDICO, Freiburg, Germany., Binninger A; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg, Germany., Spring L; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg, Germany., Jänicke M; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg, Germany., Marschner N; Praxis für interdisziplinäre Onkologie und Hämatologie, Freiburg, Germany. Electronic address: manuskript@onkologie-freiburg.de.
Jazyk: angličtina
Zdroj: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2019 Sep; Vol. 135, pp. 236. Date of Electronic Publication: 2019 Jul 22.
DOI: 10.1016/j.lungcan.2019.07.013
Databáze: MEDLINE
Externí odkaz: